Skip to main content
Premium Trial:

Request an Annual Quote

Swedish Bioinformatics Firm Ludesi Picks Up $3.4M Private Equity Investment

NEW YORK (GenomeWeb News) — Swedish venture capital group InnovationsKapital has invested SEK 25 million ($3.4 million) in Ludesi, a privately held Swedish bioinformatics company, Ludesi said yesterday.
 
Ludesi said that the funding will allow it to ramp up sales of its 2D electrophoresis gel image analysis software and to expand its product portfolio into other technologies for protein expression analysis.
 
Ludesi, founded in 2001, also counts the Sixth AP Fund and FöretagsByggarna as investors.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.